Literature DB >> 27773932

NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma.

E Pomari1,2, G Basso1, S Bresolin1,2, M Pillon1, E Carraro1, E S d'Amore3, G Viola1,2, C Frasson2, K Basso4, P Bonvini2, L Mussolin1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27773932     DOI： 10.1038/leu.2016.292

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

Review 1.  Functions of γC cytokines in immune homeostasis: current and potential clinical applications.

Authors:  Willem W Overwijk; Kimberly S Schluns
Journal:  Clin Immunol       Date:  2009-05-09       Impact factor: 3.969

2.  Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.

Authors:  Enke Baldini; Chiara Tuccilli; Natalie Prinzi; Salvatore Sorrenti; Alessandro Antonelli; Lucio Gnessi; Stefania Morrone; Costanzo Moretti; Marco Bononi; Yannick Arlot-Bonnemains; Massimino D'Armiento; Salvatore Ulisse
Journal:  Endocr Relat Cancer       Date:  2014-07-29       Impact factor: 5.678

3.  Anaplastic large cell lymphoma: twenty-five years of discovery.

Authors:  Marsha C Kinney; Russell A Higgins; Edward A Medina
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

4.  IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK.

Authors:  Qian Zhang; Hong Yi Wang; Xiaobin Liu; Gauri Bhutani; Kanchan Kantekure; Mariusz Wasik
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-29       Impact factor: 11.205

5.  Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas.

Authors:  Jonathan W Friedberg; Daruka Mahadevan; Erin Cebula; Daniel Persky; Izidore Lossos; Amit B Agarwal; Jungah Jung; Richard Burack; Xiaofei Zhou; E Jane Leonard; Howard Fingert; Hadi Danaee; Steven H Bernstein
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

6.  Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.

Authors:  Laurence Lamant; Aurélien de Reyniès; Marie-Michèle Duplantier; David S Rickman; Frédérique Sabourdy; Sylvie Giuriato; Laurence Brugières; Philippe Gaulard; Estelle Espinos; Georges Delsol
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

7.  Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

Authors:  S Eckerle; V Brune; C Döring; E Tiacci; V Bohle; C Sundström; R Kodet; M Paulli; B Falini; W Klapper; A B Chaubert; K Willenbrock; D Metzler; A Bräuninger; R Küppers; M-L Hansmann
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

Review 8.  Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.

Authors:  Véronique Minard-Colin; Laurence Brugières; Alfred Reiter; Mitchell S Cairo; Thomas G Gross; Wilhelm Woessmann; Birgit Burkhardt; John T Sandlund; Denise Williams; Marta Pillon; Keizo Horibe; Anne Auperin; Marie-Cécile Le Deley; Martin Zimmerman; Sherrie L Perkins; Martine Raphael; Laurence Lamant; Wolfram Klapper; Lara Mussolin; Hélène A Poirel; Elizabeth Macintyre; Christine Damm-Welk; Angelo Rosolen; Catherine Patte
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 9.  New insights into the regulation of T cells by gamma(c) family cytokines.

Authors:  Yrina Rochman; Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

10.  Pathobiology of anaplastic large cell lymphoma.

Authors:  Pier Paolo Piccaluga; Anna Gazzola; Claudia Mannu; Claudio Agostinelli; Francesco Bacci; Elena Sabattini; Carlo Sagramoso; Roberto Piva; Fernando Roncolato; Giorgio Inghirami; Stefano A Pileri
Journal:  Adv Hematol       Date:  2011-02-06
  10 in total
  6 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

2.  IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.

Authors:  Nina Prokoph; Nicola A Probst; Liam C Lee; Jack M Monahan; Jamie D Matthews; Huan-Chang Liang; Klaas Bahnsen; Ivonne A Montes-Mojarro; Elif Karaca-Atabay; Geeta G Sharma; Vikas Malik; Hugo Larose; Sorcha D Forde; Stephen P Ducray; Cosimo Lobello; Qi Wang; Shi-Lu Luan; Šárka Pospíšilová; Carlo Gambacorti-Passerini; G A Amos Burke; Shahid Pervez; Andishe Attarbaschi; Andrea Janíková; Hélène Pacquement; Judith Landman-Parker; Anne Lambilliotte; Gudrun Schleiermacher; Wolfram Klapper; Ralf Jauch; Wilhelm Woessmann; Gilles Vassal; Lukas Kenner; Olaf Merkel; Luca Mologni; Roberto Chiarle; Laurence Brugières; Birgit Geoerger; Isaia Barbieri; Suzanne D Turner
Journal:  Blood       Date:  2020-10-01       Impact factor: 22.113

3.  IL-2/IL-2R signaling and IL-2Rα-targeted therapy in anaplastic large cell lymphoma.

Authors:  Huan-Chang Liang
Journal:  Pathologie (Heidelb)       Date:  2022-09-12

4.  Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma.

Authors:  Elena Pomari; Federica Lovisa; Elisa Carraro; Simona Primerano; Emanuele S G D'Amore; Paolo Bonvini; Luca Lo Nigro; Rita De Vito; Luciana Vinti; Piero Farruggia; Marta Pillon; Giuseppe Basso; Katia Basso; Lara Mussolin
Journal:  Oncotarget       Date:  2017-11-11

5.  Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.

Authors:  Wenxin Luo; Panwen Tian; Yue Wang; Heng Xu; Lu Chen; Chao Tang; Yang Shu; Shouyue Zhang; Zhoufeng Wang; Jun Zhang; Li Zhang; Lili Jiang; Lunxu Liu; Guowei Che; Chenglin Guo; Hong Zhang; Jiali Wang; Weimin Li
Journal:  Int J Cancer       Date:  2018-05-07       Impact factor: 7.396

6.  miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma.

Authors:  Anna Garbin; Federica Lovisa; Antony B Holmes; Carlotta C Damanti; Ilaria Gallingani; Elisa Carraro; Benedetta Accordi; Giulia Veltri; Marco Pizzi; Emanuele S G d'Amore; Marta Pillon; Alessandra Biffi; Katia Basso; Lara Mussolin
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.